Skybiotech Healthcare Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 5, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	278	313	249	35	26	21
Market Cap Growth	-24.13%	25.65%	602.44%	36.52%	25.00%	-9.09%
Enterprise Value	368	394	249	35	26	21
Last Close Price	144.95	163.60	130.20	34.13	25.00	20.00
PE Ratio	-	-	16.24	-	-	-
PS Ratio	4.44	4.21	12.45	65.55	114.44	106.44
PB Ratio	-	2.97	2.30	1.02	0.70	0.65
P/TBV Ratio	-	5.40	2.30	1.02	0.70	0.65
P/FCF Ratio	-	-	-	-	4.26	1.63
P/OCF Ratio	-	-	-	-	4.26	1.63
EV/Sales Ratio	5.88	5.30	12.45	65.15	113.69	105.88
EV/EBITDA Ratio	-	-	13.29	-	-	-
EV/EBIT Ratio	-	-	13.29	-	-	-
EV/FCF Ratio	-	-	-	-	4.24	1.62
Debt / Equity Ratio	-	0.68	-	-	-	-
Net Debt / Equity Ratio	-	0.71	-0.78	0.00	0.00	0.00
Net Debt / EBITDA Ratio	-	-3.99	-4.50	2.98	0.33	0.39
Net Debt / FCF Ratio	-	-5.46	6.31	0.05	-0.02	-0.01
Asset Turnover	-	0.47	0.26	0.01	0.01	0.01
Quick Ratio	-	0.06	20.74	2.42	1.41	2.06
Current Ratio	-	0.75	21.14	2.87	1.91	2.06
Return on Equity (ROE)	-	-22.17%	21.44%	-0.20%	-1.09%	-1.76%
Return on Assets (ROA)	-	-9.54%	15.04%	-0.11%	-0.59%	-0.99%
Return on Invested Capital (ROIC)	-	-17.48%	52.30%	-0.21%	-1.10%	-1.77%
Return on Capital Employed (ROCE)	-	-13.70%	16.90%	-0.20%	-0.90%	-1.30%
Earnings Yield	-6.83%	-7.56%	6.16%	-0.20%	-1.46%	-2.31%
FCF Yield	-	-4.37%	-5.36%	-10.51%	23.45%	61.55%
Buyback Yield / Dilution	-	-0.00%	-84.14%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.